This site is intended for healthcare professionals
  • Home
  • /
  • Journals
  • /
  • Lung Cancer
  • /
  • Brigatinib: Novel ALK Inhibitor for Non-Small-Cell...

Brigatinib: Novel ALK Inhibitor for Non-Small-Cell Lung Cancer.

Read time: 1 mins
Published:1st Jun 2019
Author: Spencer SA, Riley AC, Matthew A, Di Pasqua AJ.
Availability: Pay for access, or by subscription
Ref.:Ann Pharmacother. 2019;53(6):621-626.
Register for free access to this exclusive healthcare learning resource

Why sign up with Medthority?

Develop your knowledge with our disease and condition focused Learning Zones

Access content from credible sources, including expert-led commentary, videos, podcasts, and webinars as well as clinical trials, treatment information and guidelines 

Personalised dashboard providing updates and recommendations for content within your areas of interest